It’s all in the mind(set): digital transformation in pharma
The importance of mindset and company culture to enable digital transformation in pharma. Top 5 Takeaways Start with defining and understanding the traditional roadblocks of...
Reputation control: changing perceptions of pharma
Amanda Barrel investigates pharma’s reputation, self-regulation, compliance and how pharma can change perceptions of the work it does. Top 5 Takeaways
1 Only 57% of people...
What’s the point…of difference? Partnership working pharma and the NHS
Barriers to partnership working are breaking, it’s time for pharma to build on its differences to be more than a supplier. James Roach and...
Looking for a breakthrough in Parkinson’s research
Will recent investments and developments offer hope for people living with Parkinson’s? Pf explores the condition and work happening to find a breakthrough in...
The missing piece: A reasoned approach to key account excellence
Sarah Taylor at Rubica Change & Analytics makes the case for a reasoned approach to key account excellence. Top 5 Takeaways Key account excellence involves...
Using big data for smart health communities
Jorge Armanet, Chief Executive and Co-founder of HealthUnlocked, discusses the big change that self-care technologies are bringing to healthcare, using big data for smart...
Leveraging data for better patient outcomes
Leveraging data for better patient outcomes. Chris Moore, President at Veeva Systems discusses how a connected and collaborative healthcare ecosystem will drive innovation and...
Reality check: The challenges of digital health
Hassan Chaudhury, Digital Health Lead, Healthcare UK, Department for International Trade, looks at the challenges of digital health and why pharma should bet big...
How bioelectronic medical devices are transforming modern healthcare
Bernard Ross, Chief Executive Officer and founder of Sky Medical Technology explores how innovative bioelectronic medical devices are transforming modern healthcare. Every 37 seconds someone in...
Pharma sales models for HCP engagement: From digitally naive to native
Pharma sales models for HCP engagement are changing quickly and indefinitely, and for businesses in the sector, Mick O'Leary of Ashfield says it’s a...
Latest articles
People with neurological conditions lose out due to COVID-19 delays
In a recent survey of more than 1600 people with neurological conditions, over 7 in 10 respondents said they had experienced delays to their...
Without support for services post COVID-19 mental health crisis awaits
The BMA is warning that we could face a post COVID-19 mental health crisis if urgent support not provided for services. The BMA says...
Major study into COVID-19 long-term health effects
The Health and Social Care Secretary has announced the launch of a major £8.4m research study into the long-term health effects of COVID-19 on...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Crisis or crossroads? Key account management post-COVID
Miranda Wheatley Price from Rubica calls for a dynamic response to the current challenge as she explores the future for key account management post-COVID. One...
Major study into COVID-19 long-term health effects
The Health and Social Care Secretary has announced the launch of a major £8.4m research study into the long-term health effects of COVID-19 on...
European Commission approves extended Invokana ® (canagliflozin) indication
The European Commission has approved an extended Invokana ® (canagliflozin) indication to reflect improved renal outcomes in patients with diabetic kidney disease and type...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...